Jun 15 |
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
|
Jun 14 |
Employee benefits survey finds marked increase in GLP-1 coverage
|
Jun 14 |
Top Stock Reports for Berkshire Hathaway, Eli Lilly & PepsiCo
|
Jun 14 |
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
|
Jun 14 |
Eli Lilly unveils new manufacturing plant for GLP-1 pens
|
Jun 14 |
June consumer sentiment disappoints, Tesla short-selling: Catalysts
|
Jun 14 |
Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research
|
Jun 14 |
Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 market
|
Jun 14 |
Alzheimer's in Focus as FDA Panel Endorses Lilly's Donanemab (Revised)
|
Jun 14 |
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
|